In addition to PC, RIPK2 is frequently amplified and/or overexpressed in several other cancer types (Supplementary Fig. 2), and its mRNA overexpression is associated with significantly shorter overall survival in nine cancer types (Supplementary Fig. 3). Here, RIPK2 is linked to cancer.